Resveratrol and curcumin suppress immune response through CD28/CTLA-4 and CD80 co-stimulatory pathway

被引：126
|
作者：
Sharma, S.
Chopra, K.
Kulkarni, S. K.
Agrewala, J. N.
机构：
[1] Inst Microbial Technol, Immunol Lab, Chandigarh 160036, India
[2] Panjab Univ, Div Pharmacol, Univ Inst Pharmaceut Sci, Chandigarh 160014, India
来源：
CLINICAL AND EXPERIMENTAL IMMUNOLOGY | 2007年 / 147卷 / 01期
关键词：
CD28; CD40; CD80; CTLA-4; curcumin; IL-10; resveratrol;
D O I：
10.1111/j.1365-2249.2006.03257.x
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
The role of resveratrol and curcumin is well documented in cancer, inflammation, diabetes and various other diseases. However, their immunosuppressive action on T cells, B cells and macrophages is not well documented. In the present study, we have ascertained the effect of resveratrol and curcumin on T and B cells and macrophages. The most striking findings were that both resveratrol and curcumin suppressed the activity of T and B cells and macrophages, as evidenced by significant inhibition in proliferation, antibody production and lymphokine secretion. Interestingly, curcumin imparted immunosuppression by mainly down-regulating the expression of CD28 and CD80 and up-regulating CTLA-4. Resveratrol also functioned by decreasing the expression of CD28 and CD80, as well as by augmenting the production of interleukin (IL)-10.
引用
收藏
页码：155 / 163
页数：9
相关论文
共 50 条
  • [41] Expression of the co-stimulatory molecules CD28, CD86, and CD80 on fresh human myeloma cells: A potential target for monoclonal antibody therapy.
    Yoong, Y
    Kimlinger, T
    Jelinek, DF
    Witzig, TE
    BLOOD, 2001, 98 (11) : 642A - 642A
  • [42] Selective requirement for CD28/CTLA-4 and CD80/CD86 in drug-induced type 1 andtype 2 antigen-specific immune responses
    不详
    IMMUNOBIOLOGY, 2004, 209 (4-6) : 353 - 354
  • [43] The Association Between CTLA-4, CD80/86, and CD28 Gene Polymorphisms and Rheumatoid Arthritis: An Original Study and Meta-Analysis
    Liu, Weixi
    Yang, Zhicheng
    Chen, Yan
    Yang, Haoyu
    Wan, Xiaoxian
    Zhou, Xindie
    Liu, Ruiping
    Zhang, Yunkun
    FRONTIERS IN MEDICINE, 2021, 8
  • [44] Plasma concentrations of soluble CTLA-4, CD28, CD80 and CD86 costimulatory molecules reflect disease severity of acute asthma in children
    Ip, W. K.
    Wong, C. K.
    Leung, T. F.
    Lam, C. W. K.
    PEDIATRIC PULMONOLOGY, 2006, 41 (07) : 674 - 682
  • [45] Augmentation of immune response by chicoric acid through the modulation of CD28/CTLA-4 and Th1 pathway in chronically stressed mice
    Kour, Kiranjeet
    Bani, Sarang
    NEUROPHARMACOLOGY, 2011, 60 (06) : 852 - 860
  • [46] Molecular and Functional Analyses of the Primordial Costimulatory Molecule CD80/86 and Its Receptors CD28 and CD152 (CTLA-4) in a Teleost Fish
    Lu, Tao-Zhen
    Liu, Xun
    Wu, Chang-Song
    Ma, Zi-You
    Wang, Yang
    Zhang, Yong-An
    Zhang, Xu-Jie
    FRONTIERS IN IMMUNOLOGY, 2022, 13
  • [47] Understanding the CD28/CTLA-4 (CD152) Pathway and Its Implications for Costimulatory Blockade
    Gardner, D.
    Jeffery, L. E.
    Sansom, D. M.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2014, 14 (09) : 1985 - 1991
  • [48] CTLA-4/CD80 pathway regulates T cell infiltration into pancreatic cancer
    Fee Bengsch
    Dawson M. Knoblock
    Anni Liu
    Florencia McAllister
    Gregory L. Beatty
    Cancer Immunology, Immunotherapy, 2017, 66 : 1609 - 1617
  • [49] CTLA-4/CD80 pathway regulates T cell infiltration into pancreatic cancer
    Bengsch, Fee
    Knoblock, Dawson M.
    Liu, Anni
    McAllister, Florencia
    Beatty, Gregory L.
    CANCER IMMUNOLOGY IMMUNOTHERAPY, 2017, 66 (12) : 1609 - 1617
  • [50] TARGETING THE IMMUNE CO-STIMULATORY MOLECULE CD80 FOR THE IMAGING OF VULNERABLE ATHEROSCLEROTIC PLAQUES BY PET
    Meletta, R.
    Mueller, A.
    Mu, L.
    Chiotellis, A.
    Borel, N.
    Rancic, Z.
    Kaufmann, P. A.
    Ametamey, S. M.
    Schibli, R.
    Kraemer, S. D.
    ATHEROSCLEROSIS, 2014, 235 (02) : E230 - E230
12345